A citation-based method for searching scientific literature

Marcello Venzi, François David, Joachim Bellet, Anna Cavaccini, Cristiano Bombardi, Vincenzo Crunelli, Giuseppe Di Giovanni. Neuropharmacology 2016
Times Cited: 38







List of co-cited articles
850 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders.
Giuseppe Di Giovanni, Philippe De Deurwaerdère. Pharmacol Ther 2016
74
42

Serotonin and epilepsy.
Gyorgy Bagdy, Valeria Kecskemeti, Pal Riba, Rita Jakus. J Neurochem 2007
221
39

Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats.
Gergely Orban, Cristiano Bombardi, Antonella Marino Gammazza, Roberto Colangeli, Massimo Pierucci, Cristoforo Pomara, Mauro Pessia, Fabio Bucchieri, Arcangelo Benigno, Ilse Smolders,[...]. CNS Neurosci Ther 2014
30
50

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors.
L H Tecott, L M Sun, S F Akana, A M Strack, D H Lowenstein, M F Dallman, D Julius. Nature 1995
990
28


Sound-induced seizures in serotonin 5-HT2c receptor mutant mice.
T J Brennan, W W Seeley, M Kilgard, C E Schreiner, L H Tecott. Nat Genet 1997
120
26


Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
William J Thomsen, Andrew J Grottick, Frederique Menzaghi, Hazel Reyes-Saldana, Stephen Espitia, Diane Yuskin, Kevin Whelan, Michael Martin, Michael Morgan, Weichao Chen,[...]. J Pharmacol Exp Ther 2008
288
26


Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
Aliesha Griffin, Kyla R Hamling, Kelly Knupp, SoonGweon Hong, Luke P Lee, Scott C Baraban. Brain 2017
103
23

High dose of 8-OH-DPAT decreases maximal dentate gyrus activation and facilitates granular cell plasticity in vivo.
Gergely Orban, Massimo Pierucci, Arcangelo Benigno, Mauro Pessia, Salvatore Galati, Mario Valentino, Richard Muscat, Giuseppe Di Giovanni. Exp Brain Res 2013
19
42

Enhanced tonic GABAA inhibition in typical absence epilepsy.
David W Cope, Giuseppe Di Giovanni, Sarah J Fyson, Gergely Orbán, Adam C Errington, Magor L Lorincz, Timothy M Gould, David A Carter, Vincenzo Crunelli. Nat Med 2009
270
21

5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
Rita Jakus, Marton Graf, Gabriella Juhasz, Katalin Gerber, Gyorgy Levay, Peter Halasz, Gyorgy Bagdy. Exp Neurol 2003
51
18

Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.
N Upton, T Stean, D Middlemiss, T Blackburn, G Kennett. Eur J Pharmacol 1998
41
18

RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
K A Berg, J D Cropper, C M Niswender, E Sanders-Bush, R B Emeson, W P Clarke. Br J Pharmacol 2001
111
18

Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
C M Burns, H Chu, S M Rueter, L K Hutchinson, H Canton, E Sanders-Bush, R B Emeson. Nature 1997
803
18

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
G A Kennett, M D Wood, F Bright, B Trail, G Riley, V Holland, K Y Avenell, T Stean, N Upton, S Bromidge,[...]. Neuropharmacology 1997
438
18


Directly Observable Behavioral Effects of Lorcaserin in Rats.
Katherine M Serafine, Kenner C Rice, Charles P France. J Pharmacol Exp Ther 2015
22
31

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.
Dubravka Svob Strac, Nela Pivac, Ilse J Smolders, Wieslawa A Fogel, Philippe De Deurwaerdere, Giuseppe Di Giovanni. Front Neurosci 2016
39
18

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.
D A Clemett, T Punhani, M S Duxon, T P Blackburn, K C Fone. Neuropharmacology 2000
283
18

Lorcaserin therapy for severe epilepsy of childhood onset: A case series.
Patricia Tolete, Kelly Knupp, Michael Karlovich, Elaine DeCarlo, Judith Bluvstein, Erin Conway, Daniel Friedman, Patricia Dugan, Orrin Devinsky. Neurology 2018
23
30

5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats.
María-Leonor López-Meraz, María-Eva González-Trujano, Leticia Neri-Bazán, Enrique Hong, Luisa Lilia Rocha. Neuropharmacology 2005
54
15

Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model.
Jo Sourbron, Henning Schneider, Angéla Kecskés, Yusu Liu, Ellen M Buening, Lieven Lagae, Ilse Smolders, Peter de Witte. ACS Chem Neurosci 2016
62
15

5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis.
Yong Xu, Juli E Jones, Daisuke Kohno, Kevin W Williams, Charlotte E Lee, Michelle J Choi, Jason G Anderson, Lora K Heisler, Jeffrey M Zigman, Bradford B Lowell,[...]. Neuron 2008
220
15

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
D Hoyer, D E Clarke, J R Fozard, P R Hartig, G R Martin, E J Mylecharane, P R Saxena, P P Humphrey. Pharmacol Rev 1994
15

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.
D Abramowski, M Rigo, D Duc, D Hoyer, M Staufenbiel. Neuropharmacology 1995
180
15

Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease.
Sylvia Navailles, Mélanie Lagière, Audrey Roumegous, Marina Polito, Méric B Boujema, Martine Cador, John Dunlop, Marie-Françoise Chesselet, Mark J Millan, Philippe De Deurwaerdère. Int J Neuropsychopharmacol 2013
26
23

The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.
Guy A Higgins, Leo B Silenieks, Anne Rossmann, Zoe Rizos, Kevin Noble, Ashlie D Soko, Paul J Fletcher. Neuropsychopharmacology 2012
109
15

5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.
J R Martin, M Bös, F Jenck, J Moreau, V Mutel, A J Sleight, J Wichmann, J S Andrews, H H Berendsen, C L Broekkamp,[...]. J Pharmacol Exp Ther 1998
264
15

Serotonin receptors and heart valve disease--it was meant 2B.
Joshua D Hutcheson, Vincent Setola, Bryan L Roth, W David Merryman. Pharmacol Ther 2011
122
15

Therapeutic Potential of 5-HT2C Receptor Agonists for Addictive Disorders.
Guy A Higgins, Paul J Fletcher. ACS Chem Neurosci 2015
56
15

Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice.
Valérie Compan, Mingming Zhou, Régis Grailhe, Russell A Gazzara, Renee Martin, Jay Gingrich, Aline Dumuis, Daniela Brunner, Joël Bockaert, René Hen. J Neurosci 2004
118
13


RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.
C M Niswender, S C Copeland, K Herrick-Davis, R B Emeson, E Sanders-Bush. J Biol Chem 1999
276
13


Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice.
S P Vickers, P G Clifton, C T Dourish, L H Tecott. Psychopharmacology (Berl) 1999
222
13


5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway.
Marcy J Bubar, Sonja J Stutz, Kathryn A Cunningham. PLoS One 2011
75
13

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Judith A Siuciak, Douglas S Chapin, Sheryl A McCarthy, Victor Guanowsky, Janice Brown, Phoebe Chiang, Ravi Marala, Terrell Patterson, Patricia A Seymour, Andrew Swick,[...]. Neuropharmacology 2007
116
13



Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.
G Engel, M Göthert, D Hoyer, E Schlicker, K Hillenbrand. Naunyn Schmiedebergs Arch Pharmacol 1986
683
13


Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Pablo R Moya, Kelly A Berg, Manuel A Gutiérrez-Hernandez, Patricio Sáez-Briones, Miguel Reyes-Parada, Bruce K Cassels, William P Clarke. J Pharmacol Exp Ther 2007
85
13


Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.
G A Higgins, L B Silenieks, W Lau, I A M de Lannoy, D K H Lee, J Izhakova, K Coen, A D Le, P J Fletcher. Psychopharmacology (Berl) 2013
40
13

Characterization of the discriminative stimulus effects of lorcaserin in rats.
Katherine M Serafine, Kenner C Rice, Charles P France. J Exp Anal Behav 2016
9
55

In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism.
L Boothman, J Raley, F Denk, E Hirani, T Sharp. Br J Pharmacol 2006
83
13

Cortical drive and thalamic feed-forward inhibition control thalamic output synchrony during absence seizures.
Cian McCafferty, François David, Marcello Venzi, Magor L Lőrincz, Francis Delicata, Zoe Atherton, Gregorio Recchia, Gergely Orban, Régis C Lambert, Giuseppe Di Giovanni,[...]. Nat Neurosci 2018
40
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.